| 000 | 01863 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515062552.0 | ||
| 264 | 0 | _c20071127 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a0145-2126 | ||
| 024 | 7 |
_a10.1016/j.leukres.2007.02.020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRohner, Andreas | |
| 245 | 0 | 0 |
_aDifferentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis. _h[electronic resource] |
| 260 |
_bLeukemia research _cOct 2007 |
||
| 300 |
_a1393-402 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aAzacitidine _xadministration & dosage |
| 650 | 0 | 4 |
_aBryostatins _xadministration & dosage |
| 650 | 0 | 4 | _aCell Differentiation |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCholecalciferol _xadministration & dosage |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 | _aDecitabine |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aGPI-Linked Proteins |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxamic Acids _xadministration & dosage |
| 650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xmetabolism |
| 650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _ximmunology |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aTretinoin _xadministration & dosage |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aLangenkamp, Ulrich | |
| 700 | 1 | _aSiegler, Uwe | |
| 700 | 1 | _aKalberer, Christian P | |
| 700 | 1 | _aWodnar-Filipowicz, Aleksandra | |
| 773 | 0 |
_tLeukemia research _gvol. 31 _gno. 10 _gp. 1393-402 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.leukres.2007.02.020 _zAvailable from publisher's website |
| 999 |
_c16945765 _d16945765 |
||